Diaceutics PLC
DIUXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $42,180 | $92,756 | $91,464 | $90,696 |
| - Cash | $10,384 | $12,744 | $16,749 | $16,667 |
| + Debt | $1,134 | $1,060 | $150 | $1,205 |
| Enterprise Value | $32,930 | $81,072 | $74,865 | $75,234 |
| Revenue | $14,564 | $19,838 | $12,320 | $13,775 |
| % Growth | -26.6% | 61% | -10.6% | – |
| Gross Profit | $12,087 | $17,539 | $8,613 | $11,006 |
| % Margin | 83% | 88.4% | 69.9% | 79.9% |
| EBITDA | -$1,341 | $2,667 | -$961 | $1,571 |
| % Margin | -9.2% | 13.4% | -7.8% | 11.4% |
| Net Income | -$2,401 | $881 | -$2,584 | -$261 |
| % Margin | -16.5% | 4.4% | -21% | -1.9% |
| EPS Diluted | -0.057 | 0.01 | -0.031 | -0.003 |
| % Growth | -646.2% | 134% | -887.1% | – |
| Operating Cash Flow | $605 | -$501 | $1,501 | $613 |
| Capital Expenditures | -$55 | -$39 | -$61 | -$64 |
| Free Cash Flow | $550 | -$540 | $1,440 | $549 |